Range
- - -
Vol / Avg.
-/169.2K
Div / Yield
-
52 Wk
6.36 - 11.38
Mkt Cap
321.6M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.28
Shares
49M
Outstanding
49M
Total Float
43.5M
Sector: Health Care.Industry: Biotechnology
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.170-0.280 -0.1100
REV0
Q4 2020Est.ActualSurprise
EPS-0.310-0.340 -0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AGLEAeglea BioTherapeutics0%321.6M

Aeglea BioTherapeutics Frequently Asked Questions

Q

How do I buy Aeglea BioTherapeutics (AGLE) stock?

A

You can purchase shares of Aeglea BioTherapeutics (NASDAQ: AGLE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aeglea BioTherapeutics's (AGLE) competitors?

Q

What is the target price for Aeglea BioTherapeutics (AGLE) stock?

A

The latest price target for Aeglea BioTherapeutics (NASDAQ: AGLE) was reported by HC Wainwright & Co. on November 9, 2020. The analyst firm set a price target for 15.00 expecting AGLE to rise to within 12 months (a possible 128.66% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aeglea BioTherapeutics (AGLE)?

A

The stock price for Aeglea BioTherapeutics (NASDAQ: AGLE) is $6.56 last updated Tue Jun 15 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Aeglea BioTherapeutics (AGLE) pay a dividend?

A

There are no upcoming dividends for Aeglea BioTherapeutics.

Q

When is Aeglea BioTherapeutics (NASDAQ:AGLE) reporting earnings?

A
Aeglea BioTherapeutics’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Aeglea BioTherapeutics (AGLE) going to split?

A

There is no upcoming split for Aeglea BioTherapeutics.

Q

What sector and industry does Aeglea BioTherapeutics (AGLE) operate in?

A

Aeglea BioTherapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.